<\/p>\n
On 28 April, a working meeting was held at the State Expert Centre of the Ministry of Health of Ukraine, with the participation of Yevheniia Ishkova, Deputy Director for Health Technology Assessment and Clinical Trials, Taisa Herasymchuk, Director of the Department for Evaluation of Preclinical and Clinical Trial Materials, and Iryna Magdik, Executive Director of the Clinical Trials Subcommittee of the European Business Association.<\/p>\n
During the meeting, participants discussed key organisational aspects of preparing the National Forum \u201cMedicine Without Borders: Services, Innovations and Medical Partnerships\u201d, in particular the development of a dedicated clinical trials track, which is expected to serve as a platform for constructive dialogue between public authorities, business, and international partners.<\/p>\n
Special attention was paid to secondary legislation required for the implementation of the new Law of Ukraine \u201cOn Medicinal Products\u201d, as well as to changes in the regulation of clinical trials that require further refinement in the context of launching an updated regulatory framework.<\/p>\n
The parties also discussed the preparation of a memorandum of cooperation aimed at restoring and developing clinical trials in Ukraine amid the establishment of a new regulatory authority, ongoing European integration processes, and the challenging realities of the full-scale war. The memorandum is intended to lay the foundation for systematic cooperation between the regulator and business, and to support Ukraine\u2019s competitiveness as a location for clinical research.<\/p>\n
In addition to strategic issues, several operational aspects were addressed, including the organisation of an online working meeting with pharmaceutical companies and contract research organisations (CROs) to discuss and resolve technical matters related to the implementation of electronic submission via the applicant\u2019s portal. The meeting is scheduled for Thursday, 7 May. Further details will be communicated in due course.<\/p>\n
The meeting marked another step towards strengthening partnership dialogue and developing practical solutions for the sustainable development of clinical trials in Ukraine.<\/p>\n
<\/p>","protected":false},"excerpt":{"rendered":"
On 28 April, a working meeting was held at the State Expert Centre of the Ministry of Health of Ukraine, with the participation of Yevheniia Ishkova, Deputy Director for Health Technology Assessment and Clinical Trials, Taisa Herasymchuk, Director of the Department for Evaluation of Preclinical and Clinical Trial Materials, and Iryna Magdik, Executive Director of […]<\/p>\n","protected":false},"author":33544,"featured_media":738364,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[4,5,22],"tags":[],"yoast_head":"\n